Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 1346951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors compared vitamin E with placebo in a double-blind randomized crossover study of 27 patients with tardive dyskinesia. Each treatment period lasted for 6 weeks. Vitamin E showed no differences from placebo in the treatment of tardive dyskinesia.
Medical subject headings
- Dyskinesia, Drug-Induced
- Vitamin E